This inventor holds 3 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: Eliahu Roubini: Innovator in Peptide Hormone Analogues
Introduction
Eliahu Roubini is a notable inventor based in Lensvale, PA (US). He has made significant contributions to the field of peptide hormone analogues, holding a total of 3 patents. His work focuses on the modification of peptide structures to enhance biological activity.
Latest Patents
Roubini's latest patents include innovative approaches to peptide hormone analogues. One of his inventions, titled "Antagonists with position 13 modification," relates to the use of peptide hormone analogues as inhibitors of their naturally occurring counterparts. This invention exemplifies the structure of parathyroid hormone (PTH), where Lys.sup.13 is substituted to increase the biological activity of the PTH analogues. Another significant patent involves humoral hypercalcemic factor antagonists modified at position 13, which utilizes peptide analogues to inhibit the action of human humoral hypercalcemic factor (hHCF).
Career Highlights
Eliahu Roubini has established a successful career at Merck & Co., Inc., where he continues to innovate in the field of biochemistry. His research has led to advancements in understanding peptide hormone interactions and their potential therapeutic applications.
Collaborations
Throughout his career, Roubini has collaborated with esteemed colleagues, including Michael Rosenblatt and Michael Chorev. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking inventions.
Conclusion
Eliahu Roubini's contributions to the field of peptide hormone analogues demonstrate his commitment to innovation and scientific advancement. His patents reflect a deep understanding of biochemistry and its applications in medicine.